Marathon is now focused on developing rare disease treatments and has divested non-strategic products to Valeant Pharmaceuticals.

Image does not depict an actual patient

What if rare disease treatments started with the patient?

More

What does it take to keep medicines available?

More

How can there still be 6,000 diseases without treatment?

More
Image does not depict an actual patient

How can we make a greater difference in patients’ lives?

More

How can we be sure all patients get the medication they need?

More

Why are rare diseases so difficult to treat?

More
Image does not depict an actual patient

What sort of company focuses on small patient groups?

More

What does it take to bring rare disease treatments to patients?

More

How can we identify unmet medical needs?

More

 

 

News

Team

Proven leaders in developing rare disease treatments

More

Treatment pipeline

Developing new treatments
for people with rare diseases

More